Efficacy and safety of febuxostat in the treatment of hyperuricemia in stable kidney transplant recipients

References

• Abbott KC Kimmel PL Dharnidharka V Oglesby RJ Agodoa LY Caillard S New-onset gout after kidney transplantation: incidence, risk factors and implications Transplantation 2005 80 10 1383 1391 16340779
   PubMed Web of Science ®Google Scholar
• Clive DM Renal transplant-associated hyperuricemia and gout J Am Soc Nephrol 2000 11 5 974 979 10770978
   PubMed Web of Science ®Google Scholar
• Numakura K Satoh S Tsuchiya N Hyperuricemia at 1 year after renal transplantation, its prevalence, associated factors, and graft survival Transplantation 2012 94 2 145 151 22728291
   PubMed Web of Science ®Google Scholar
• Bahn A Hagos Y Reuter S Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13) J Biol Chem 2008 283 24 16332 16341 18411268
   PubMed Web of Science ®Google Scholar
• Ishikawa I Maekawa S Saito T Horiguchi T Shinoda A Ishii H Mizoribine-induced hyperuricemia Nihon Jinzo Gakkai Shi 1986 28 10 1353 1357 Japanese 3546871
   PubMedGoogle Scholar
• Goicoechea M de Vinuesa SG Verdalles U Effect of allopurinol in chronic kidney disease progression and cardiovascular risk Clin J Am Soc Nephrol 2010 5 8 1388 1393 20538833
   PubMed Web of Science ®Google Scholar
• Miao Y Ottenbros SA Laverman GD Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial Hypertension 2011 58 1 2 7 21632472
   PubMed Web of Science ®Google Scholar
• Haririan A Metireddy M Cangro C Association of serum uric acid with graft survival after kidney transplantation: a time-varying analysis Am J Transplant 2011 11 9 1943 1950 21812917
   PubMed Web of Science ®Google Scholar
• Min SI Yun IJ Kang JM Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome Nephrol Dial Transplant 2009 24 8 2584 2590 19395726
   PubMed Web of Science ®Google Scholar
• Akalin E Ganeshan SV Winston J Muntner P Hyperuricemia is associated with the development of the composite outcomes of new cardiovascular events and chronic allograft nephropathy Transplantation 2008 86 5 652 658 18791445
   PubMed Web of Science ®Google Scholar
• Huang Y Li YL Huang H Wang L Yuan WM Li J Effects of hyperuricemia on renal function of renal transplant recipients: a systematic review and meta-analysis of cohort studies PLoS One 2012 7 6 e39457 22745759
   PubMed Web of Science ®Google Scholar
• Day RO Graham GG Hicks M McLachlan AJ Stocker SL Williams KM Clinical pharmacokinetics and pharmacodynamics of allopurinol and oxypurinol Clin Pharmacokinet 2007 46 8 623 644 17655371
   PubMed Web of Science ®Google Scholar
• Uloric® Full Prescribing information Deerfield, IL, USA Takeda Pharmaceuticals North America, Inc 2009
   Google Scholar
• Becker MA Schumacher HR Espinoza LR The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial Arthritis Res Ther 2010 12 2 R63 20370912
   PubMed Web of Science ®Google Scholar
• Becker MA Schumacher HRJr Wortmann RL Febuxostat compared with allopurinol in patients with hyperuricemia and gout N Engl J Med 2005 353 23 2450 2461 16339094
   PubMed Web of Science ®Google Scholar
• Zhang W Doherty M Pascual E EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) Ann Rheum Dis 2006 65 10 1301 1311 16707533
   PubMed Web of Science ®Google Scholar
• Matsuo S Imai E Horio M Collaborators developing the Japanese equation for estimated GFR Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 2009 53 6 982 992 19339088
   PubMed Web of Science ®Google Scholar
• Sofue T Inui M Kiyomoto H Pre-existing arteriosclerotic intimal thickening in living-donor kidneys reflects allograft function Am J Nephrol 2012 36 2 127 135 22797609
   PubMed Web of Science ®Google Scholar
• Sofue T Inui M Hara T Short-term prognosis of living-donor kidney transplantation from hypertensive donors with high-normal albuminuria Transplantation 2014 15 97 1 104 110 24092387
   PubMed Web of Science ®Google Scholar
• Sofue T Inui M Kiyomoto H Excess fluid distribution affects tacrolimus absorption in peritoneal dialysis patients Clin Exp Nephrol 2013 17 5 743 749 23269423
   PubMed Web of Science ®Google Scholar
• Jacobs F Mamzer-Bruneel MF Skhiri H Thervet E Legendre C Kreis H Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout Transplantation 1997 64 7 1087 1088 9381537
   PubMed Web of Science ®Google Scholar
• Chonchol M Shlipak MG Katz R Relationship of uric acid with progression of kidney disease Am J Kidney Dis 2007 50 2 239 247 17660025
   PubMed Web of Science ®Google Scholar
• Kanbay M Huddam B Azak A A randomized study of allopurinol on endothelial function and estimated glomerular filtration rate in asymptomatic hyperuricemic subjects with normal renal function Clin J Am Soc Nephrol 2011 6 8 1887 1894 21784838
   PubMed Web of Science ®Google Scholar
• Ito S Naritomi H Ogihara T Impact of serum uric acid on renal function and cardiovascular events in hypertensive patients treated with losartan Hypertens Res 2012 35 8 867 873 22573200
   PubMed Web of Science ®Google Scholar
• Mikkelsen WM Dodge HJ Valkenburg H The distribution of serum uric acid values in a population unselected as to tout or hyperuricemia: Tecumseh, Michigan 1959–1960 Am J Med 1965 39 2 242 251 14320691
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group KDIGO clinical practice guideline for the care of kidney transplant recipients Am J Transplant 2009 9 Suppl 3 S1 S155
   PubMed Web of Science ®Google Scholar
• Patwardhan MB Samsa GP Matchar DB Haley WE Advanced chronic kidney disease practice patterns among nephrologists and non-nephrologists: a database analysis Clin J Am Soc Nephrol 2007 2 2 277 283 17699425
   PubMed Web of Science ®Google Scholar
• Van Arendonk KJ Garonzik Wang JM Deshpande NA Practice patterns and outcomes in retransplantation among pediatric kidney transplant recipients Transplantation 2013 95 11 1360 1368 23549198
   PubMed Web of Science ®Google Scholar
• Sanchez-Lozada LG Tapia E Soto V Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia Nephrol Dial Transplant 2008 23 4 1179 1185 18048425
   PubMed Web of Science ®Google Scholar
• Siu YP Leung KT Tong MK Kwan TH Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level Am J Kidney Dis 2006 47 1 51 59 16377385
   PubMed Web of Science ®Google Scholar
• Neal DA Tom BD Gimson AE Gibbs P Alexander GJ Hyperuricemia, gout, and renal function after liver transplantation Transplantation 2001 72 10 1689 1691 11726834
   PubMed Web of Science ®Google Scholar
• Tsuchiya N Satoh S Tada H Influence of CYP3A5 and MDR1 (ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients Transplantation 2004 78 8 1182 1187 15502717
   PubMed Web of Science ®Google Scholar
• Bekersky I Dressler D Mekki Q Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose J Clin Pharmacol 2001 41 3 289 297 11269569
   PubMed Web of Science ®Google Scholar
• MacPhee IA Fredericks S Tai T The influence of pharmacogenetics on the time to achieve target tacrolimus concentrations after kidney transplantation Am J Transplant 2004 4 6 914 919 15147425
   PubMed Web of Science ®Google Scholar